MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Pre-Tax Margin
Income before tax as a percentage of revenue.
MetLife, Inc.NYSE: MET
Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026
Pre-tax margin holds steady near 5.5%
Pre-tax margin was 5.5% in Q2 FY2026, down 0.2 pp from a year earlier. On a trailing-twelve-month basis it was 6.2%, down 1.7 pp year over year. Over 3 fiscal years it narrowed by 3.3 pp.
Context
- Pre-tax margin widened in 1 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 6.0%
- Year-over-year change
- -2.0pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.0% | -2.0pp |
| FY2024 | 2024-12-31 | 8.0% | +4.8pp |
| FY2023 | 2023-12-31 | 3.2% | -6.2pp |
| FY2022 | 2022-12-31 | 9.4% | -4.1pp |
| FY2021 | 2021-12-31 | 13.4% | — |
Pre-Tax Margin vs competitors
How MET compares with its peers on the latest reported figures
- MET's LTM Jun 2026 pre-tax margin of 6.2% is the lowest of the 11 companies compared; the peer median is 14.6%.
- Its year-over-year change of -1.7 pp is the 9th highest of 11, against a peer median of +2.0 pp.
- Over three fiscal years its change of -3.3 pp compares with a peer median of +1.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 32.0% | +12.3 pp | +0.6 pp | |
| LTM Sep 2026 | 29.7% | +0.3 pp | +3.2 pp | |
| LTM Sep 2026 | 23.3% | -0.6 pp | +2.9 pp | |
| LTM Jun 2026 | 19.6% | +4.6 pp | +3.9 pp | |
| LTM Jun 2026 | 14.6% | +7.5 pp | -1.8 pp | |
| LTM Sep 2026 | 14.6% | -5.0 pp | -63.7 pp | |
| LTM Jun 2026 | 14.5% | +3.7 pp | +26.4 pp | |
| LTM Jun 2026 | 7.7% | +4.0 pp | +11.1 pp | |
| LTM Jun 2026 | 7.7% | -0.5 pp | -16.3 pp | |
| LTM Jun 2026 | 6.8% | -8.1 pp | -7.6 pp | |
| LTM Jun 2026 | 6.2% | -1.7 pp | -3.3 pp | |
| Peer median (excluding MET) | 14.6% | +2.0 pp | +1.7 pp | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.